Introduction {#S0001}
============

Dental implants have become a widespread and effective method for treatment of fully and partially edentulous patients. Nonetheless, implant failure still occurs. Global implant failure rate has been reported to be between 1.9% and 3.6%.[@CIT0001]--[@CIT0003] Implant failures can be divided into two types based on timing: early and late.[@CIT0004] Early failure occurs before abutment connection and is caused by failed osseointegration.[@CIT0004] This can be the result of failure in the bone-healing process, where formation of scar tissue or inflammatory cell proliferation prevents the implant from adhering tightly to the bone.[@CIT0005] Late failure occurs after osseointegration has occurred and the implant is subjected to occlusal loading.[@CIT0005] Alveolar bone loss has been shown to be a primary cause of late implant failure.[@CIT0004]

Peri-implantitis,[@CIT0040] occlusal overloading,[@CIT0041] systemic comorbid conditions,[@CIT0042] medication regimen,[@CIT0043] patient unhealthy behaviors,[@CIT0044] and implant location[@CIT0045] and characteristics[@CIT0046] are among risk factors associated with implant failure.[@CIT0047] Dental implants have been suggested to exhibit cluster behavior, where a small proportion of patients are responsible for the majority of implant failures.[@CIT0006],[@CIT0052] In one study, 58.6% of the overall implant failures occurred in just 32.1% of the patients.[@CIT0006] This suggests that these patients may have endogenous characteristics which predispose them to implant failure. Because of the high financial burden of dental implant treatment, it is important to understand the cause of these cluster failure patients in order to develop screening techniques for implant viability. A variety of primary predictors for implant failure have already been identified, such as advanced age, diabetes, smoking, and implant location.[@CIT0007] However, the relationship between genetic factors and implant failure susceptibility is poorly understood.

Previously, certain candidate genes have been identified and investigated for their relationship to periodontal disease.[@CIT0038] Polymorphisms involved in host inflammatory response such as inflammatory cytokines have been extensively investigated for their potential role in susceptibility to aggressive forms of periodontitis.[@CIT0039] Other gene polymorphisms, such as Vitamin D receptor genes involved in regulating bone mineral density or matrix metalloproteinase genes involved in connective tissue destruction, have also been implicated as risk factors for periodontal disease.[@CIT0008] The etiology of dental implant failure shows many parallels with that of periodontal disease due to the involvement of soft tissue damage, infection, and bone loss.[@CIT0009] For this reason, many studies examining the relationship between genetic polymorphisms and implant failure have examined the same candidate genes as for periodontal disease. The purpose of this scoping review was to 1) conduct a scoping review of articles examining the relationship between specific gene polymorphisms and dental implant failure and 2) discuss possible biological mechanisms which could explain these relationships.

Methods {#S0002}
=======

The purpose of a scoping review has been defined as a method to quickly map out the available literature regarding an area of research. From here, gaps in the available literature can be identified so that further studies can be pursued.[@CIT0010] The scoping review methodology as defined by Arksey and O'Malley[@CIT0010] has five major steps: Identify a research questionIdentify relevant studiesEvaluate and select studies to be includedChart the dataCollect, summarize, and report the results

Research question {#S0002-S2001}
-----------------

The primary goal of this scoping review was to identify single nucleotide polymorphisms (SNPs) which could potentially be associated with dental implant failure so that they could be studied further. Based on this goal, the research question developed was "Which gene polymorphisms show an association with dental implant failure?"

Search strategy {#S0002-S2002}
---------------

We conducted an electronic literature search on the PubMed and Scopus database in order to identify potential papers to be included in the study. The studies included were available in English and published from the year 2000 to the present day. We used the following Boolean search term: (dental implant failure) AND ("polymorphism" OR "genotype" OR "haplotype"). This search yielded 78 potential papers to be included in the study.

Study selection {#S0002-S2003}
---------------

The following inclusion criteria were established during the process of reviewing the articles: The study had to explicitly study dental implant failure resulting in implant loss, including both early and late failures. Studies which included other conditions such as peri-implantitis were excluded.Studies had to be done on human subjects.The study had to specifically target one or more SNPs.Any follow-up period was acceptable.Only case-control studies were considered in order to maintain homogeneity of studies analyzed.

After defining these criteria, the title and abstract of each paper were reviewed to determine eligibility. This review resulted in 21 papers which were relevant to the research question and satisfied the exclusion criteria based on a preliminary review. Each of these papers were then read in detail and reviewed more thoroughly, resulting in 16 papers to be included in the final study. The overall screening process is detailed in [Figure 1](#F0001){ref-type="fig"}.Figure 1Study search and exclusion process.

Data extraction {#S0002-S2004}
---------------

The first author and date of publication were recorded for each of the included studies. Then, we determined whether the study looked at early implant failures only or all implant failures. Finally, we examined the exact polymorphism which was the subject of study, the characteristics of the patient samples used, the minimum duration that healthy controls needed to have their implants to be included in the study, and the results regarding the association of the polymorphism with implant failures. The specific characteristics for each study can be found in [Table 1](#T0001){ref-type="table"}. We also identified the specific methodology used in the studies, the sample size of both patients and total number of implants, as well as any other factors which could contribute to implant failure identified in the study. These characteristics can be found for each of these studies in [Table 2](#T0002){ref-type="table"}. For the "Statistical Findings for Study SNP" column of [Table 2](#T0002){ref-type="table"}, all included odds ratios or other findings were specified as statistically significant within their respective articles.Table 1Summary of SNPs, follow-up period, and association results of the studies includedAuthorSNPImplant survival periodResultsPigossi et al, 2014[@CIT0023]IL-4 (+33)6 mo.Associated with implant failureCosyn et al, 2016[@CIT0013]IL-1A (−889), IL-1B (+3954)1--4 yrs.Both polymorphisms associated with early implant failureJacobi-Gresser et al, 2013[@CIT0024]IL-1A (−889)5.2 yrs.Borderline significant association with implant failureCosta Junior et al, 2012[@CIT0015]MMP-8 (−799)9 mo.Associated with early implant failureDirschnabel et al, 2011[@CIT0017]IL-1B (−551)6 mo.Borderline significant association with multiple implant failuresMontes et al, 2009[@CIT0018]IL-1RN allele 26 mo.No association with implant failureRogers et al, 2002[@CIT0026]IL-1A (−889), IL-1B (+3953)Not specifiedNo association with implant failureDoetzer et al, 2014[@CIT0021]LTF rs6441989, LTF rs2073495, LTF rs117164976 mo.No association with implant failurePigossi et al, 2012[@CIT0022]IL-10 (−1082), IL-10 (−819). IL-10 (−512)6 mo.No association with implant failureGurol et al, 2011[@CIT0019]IL-10 (−1082), IL-10 (−819), TNF-α (−308)6 mo.No association with late implant failureAlvim-Pereira et al, 2008[@CIT0020]VDR rs7312366 mo.No association with implant failureCampos et al, 2005[@CIT0012]IL-2 (−330), IL-6 (−174)1 yr.No association with early implant failureDos Santos et al, 2004[@CIT0016]TGF1-β (−509), TGF1-β (−800)1 yr.No association with early implant failureCampos et al, 2004[@CIT0011]TNF-α (−308)1 yr.No association with early implant failureMunhoz et al, 2017[@CIT0025]MMP-3 (−1612)1 yr.No association with implant failureLeite et al, 2008[@CIT0014]MMP-1 (−519), MMP-1 (−1607)9 mo.Haplotype association with early implant failure Table 2Summary of study characteristics and significant confounders in the studies includedAuthorStudy designNumber of patientsNumber of implantsStatistical findings for study SNPOther characteristics associated with implant failurePigossi et al, 2014[@CIT0023]Case-control matched by gender, age, and smoking status94 cases, 186 controls135 failed, 1,232 healthyIL-4+33 C allele: 1.61 OR \[1.1--2.4 95% CI\]Edentulism (2.405 OR)Cosyn et al, 2016[@CIT0013]Case-control matched by gender, age, and smoking status14 cases, 14 controlsNot specifiedIL-1A −889 T allele: 3.9 OR, IL-1B +3954 T allele: 15.0 ORJacobi-Gresser et al, 2013[@CIT0024]Unmatched case-control41 cases, 68 controlsNot specifiedIncreased number of risk alleles: 1.57 OR \[1.01--2.44 95% CI\]Increased TNF-α/IL-1β assay levels (12.01 OR), Male gender (2.78 OR)Costa Junior et al, 2012[@CIT0015]Case-control matched by gender and age80 cases, 100 controlsNot specifiedMMP-8 −799 T allele had higher prevalence in case groupDirschnabel et al, 2011[@CIT0017]Case-control matched by gender, age, and smoking status92 cases, 185 controlsNot specifiedNo statistically significant differencesMedical treatment for systemic disease, edentulism, increased number of implants placed, increased probing pocket depthMontes et al, 2009[@CIT0018]Case-control matched by gender, age, and smoking status90 cases, 176 controls135 failed, 1232 healthyIL1RN 2/2 genotype: 3.07 OR of multiple losses \[1.13--8.34 95% CI\]Increased probing pocket depthRogers et al, 2002[@CIT0026]Unmatched case-control119 cases, 60 controlsNot specifiedNo statistically significant differencesDoetzer et al, 2014[@CIT0021]Case-control study matched by age, gender, ethnicity, and smoking status94 cases, 184 controlsNot specifiedNo statistically significant differencesMedical treatment for systemic disease (2.085 OR), Use of hormonal reposition medication (2.085 OR), edentulismPigossi et al, 2012[@CIT0022]Case-control matched by gender, age, and smoking status92 cases, 185 controlsNot specifiedNo statistically significant differencesGurol et al, 2011[@CIT0019]Unmatched case-control16 cases, 34 controlsNot specifiedNo statistically significant differencesAlvim-Pereira et al, 2008[@CIT0020]Case-control matched by gender, age, and smoking status80 cases, 137 controls135 failed, 1,232 healthyNo statistically significant differencesEdentulism, increased number of implants placed, increased probing pocket depthCampos et al, 2005[@CIT0012]Unmatched case-control34 cases, 40 controlsNot specifiedNo statistically significant differencesDos Santos et al, 2004[@CIT0016]Unmatched case-control28 cases, 40 controlsNot specifiedNo statistically significant differencesCampos et al, 2004[@CIT0011]Unmatched case-control28 cases, 38 controlsNot specifiedNo statistically significant differencesMunhoz et al, 2017[@CIT0025]Case-control matched by gender and age120 cases, 120 controlsNot specifiedNo statistically significant differencesLeite et al, 2008[@CIT0014]Unmatched case-control44 cases, 60 controlsNot specifiedMMP-1 −1607 G allele and MMP −519 AGG allele had higher prevalence in case group

Results {#S0003}
=======

Characteristics of the included studies {#S0003-S2001}
---------------------------------------

The included studies examined different categories of implant failures. Six of the papers studied early implant failure only.[@CIT0011]--[@CIT0016] Two papers studied patients with both early and late implant failures but only had statistically significant findings with patients who experienced multiple implant failures.[@CIT0017],[@CIT0018] Only one paper excluded early implant failures.[@CIT0018] All of the remaining papers studied all types of implant failure.

All of the selected papers were case-control studies; however, they varied in their criteria for selection of the controls. Two of the papers selected patients whose implants had survived at least 9 months.[@CIT0015],[@CIT0016] Seven of the papers selected patients whose implants had survived at least 6 months.[@CIT0016]--[@CIT0022] Rogers et al did not specify the minimum implant survival duration. All of the remaining papers chose patients whose implants survived 1 year or longer.[@CIT0011]--[@CIT0013],[@CIT0024],[@CIT0025] These studies also varied in how they designed their case-control study. Six studies were unmatched case-control studies. The rest were matched.

Many of the papers used the same or similar patient pools. In particular, six studies drew their study sample from the exact same pool of 3,758 patient records from the Latin-American Dental Research Institute (ILAPEO) of Curitiba.[@CIT0017],[@CIT0018],[@CIT0020]--[@CIT0023] Six of the studies used patient pools which included patients treated at University of Campinas, Piracicaba, Sao Paulo, Brazil.[@CIT0011],[@CIT0012],[@CIT0014]--[@CIT0016],[@CIT0025] The remaining studies used patient pools from Belgium, Germany, Australia, and Turkey.[@CIT0013],[@CIT0019],[@CIT0024],[@CIT0026]

Nine of the papers studied interleukin polymorphisms.[@CIT0012],[@CIT0013],[@CIT0017]--[@CIT0019],[@CIT0022]--[@CIT0024],[@CIT0026] Specifically, polymorphisms of IL-1A, IL-1B, IL-1RN, IL-2, IL-4, IL-6, and IL-10 were studied. Three of the papers studied matrix metalloproteinases, specifically MMP-1, MMP-3, and MMP-8.[@CIT0012],[@CIT0013],[@CIT0023] The remaining polymorphisms studied were TNF-α, TGF1-β, lactoferrin, and vitamin D receptors.[@CIT0011],[@CIT0016],[@CIT0019]--[@CIT0021]

Only four of the polymorphisms were the subject of more than one of the examined studies. The IL-1A (−889) polymorphism was the subject of three studies.[@CIT0013],[@CIT0024],[@CIT0026] The IL-10 (−1082), IL-10 (−819), and the TNF-α (−308) polymorphisms were the subject of two studies each.[@CIT0011],[@CIT0019],[@CIT0022]

Effects of SNPs on implant failure {#S0003-S2002}
----------------------------------

The general characteristics and results of the studies included are displayed in [Table 1](#T0001){ref-type="table"}. Information regarding the sample size, methodology, and statistical findings of each study can be found in [Table 2](#T0002){ref-type="table"}. The most highly studied polymorphism was the IL-1A (−889) C to T polymorphism. Cosyn et al found a statistically significant association between the T allele and early implant failure in a Belgian poulation, with a 3.9 OR.[@CIT0013] However, this study had a limited sample size, with only 14 cases and 14 controls. The other two studies examined both early and late failures and failed to find a statistically significant result, although Jacobi-Gresser et al found a borderline significant association (*p*=0.077).[@CIT0024] The IL-1A interleukin has been previously linked to peri-implantitis, which is one of the most common causes of late implant failure.[@CIT0028] The only study which showed a statistically significant association between the IL-1A polymorphism and implant failure, however, was the study which examined only early implant failures. This discrepancy in the findings could either be an indication of lack of statistical power in the first study, or an indication that the IL-1A interleukin plays a role in osseointegration which is not yet understood.

The IL-1B interleukin was the subject of four different studies. IL-1B has been demonstrated to stimulate a wide variety of cells which are involved in inflammatory responses, such as neutrophils and fibroblasts.[@CIT0027] Cosyn et al examined the IL-1B (+3954) polymorphism and found an OR of 15.0 for patients who had the T allele and early implant failure.[@CIT0013] As stated above, however, this study suffers from a limited sample size. Of the 14 controls used in the study, only one T allele was present within the entire sample, so it is unclear whether these results can be extrapolated to a larger population sample. Montes et al also looked at the IL-1b (+3954) polymorphism, however they used a Brazilian population and did not distinguish between early and late implant failures.[@CIT0018] Their study found no statistically significant association between the T allele and implant failure while using a much larger sample size of 176 controls and 90 cases.[@CIT0018] Rogers et al did not distinguish between early and late implant failures and examined the IL-1B (+3953) polymorphism in an Australian population.[@CIT0026] They found no significant difference in prevalence of allele 2 between individuals with failed implants and individuals with successful implants. Dirschnabel et al examined the IL-1B (−551) polymorphism within a Brazilian population and found a borderline significant difference (*p*=0.083) in the prevalence of the TT genotype between patients with zero to one implant failures and patients with multiple implant failures.[@CIT0017] These findings could either indicate that IL-1B polymorphisms have some specific effect on initial osseointegration but not affect later stages of implant survival, or that the first study lacked enough statistical power to generate a reproducible result. In addition, Cosyn et al and Montes et al matched their cases and controls by smoking status, whereas Rogers et al only matched by age and gender. Tobacco use is a major confounding factor of implant failure, and further studies could benefit from ensuring that cases and controls are always matched by smoking status.[@CIT0007]

Two papers studied IL-10 polymorphisms. IL-10 is an anti-inflammatory cytokine which inhibits the production of proinflammatory cytokines, making it an important mediator of the immunosuppressive response.[@CIT0029] Polymorphisms which affect levels of IL-10 transcription could therefore lead to increased inflammation, resulting in implant failure. Pigossi et al examined the IL-10 (−1082), (−819), and (−592) polymorphisms within a Brazilian population and found no statistically significant associations between any of the polymorphisms and dental implant failure.[@CIT0022] Gurol et al also examined the IL-10 (−1082) and (−819) polymorphisms but within a Turkish population and also found no statistically significant associations between the polymorphisms and implant failure.[@CIT0019]

Two papers studied the TNF-α (−308) polymorphisms. TNF-α is a proinflammatory cytokine produced by macrophages and could influence implant failure through similar mechanisms as the interleukins discussed above.[@CIT0030] Gurol et al examined the TNF-α (−308) polymorphism in a Turkish population and found no statistically significant association.[@CIT0019] Campos et al looked at the same polymorphism within a Brazilian population and also found no statistically significant association.[@CIT0011] This study excluded smokers from their study sample and noted that this exclusion created a fairly small sample size of 38 controls and 28 cases. The first study contained a fairly small sample size of 23 controls and 16 cases as well.

All of the remaining polymorphisms were only studied once each within the selected papers. Four other interleukin polymorphisms were studied. Of these, two produced statistically significant results. Pigossi et al examined the IL-4 (+33) polymorphism within a Brazilian population and found that individuals carrying the C allele had a 1.61 OR of dental implant loss.[@CIT0023] IL-4 is a T-cell secreted interleukin that inhibits macrophage secretion of proinflammatory cytokines and PGE~2,~ and insufficient IL-4 has been implicated to be a potential trigger of periodontitis.[@CIT0027] Montes et al examined the presence of intron 2 in the IL-1RN gene compared to the presence of any of the other introns.[@CIT0018] Although no statistically significant association was found between the presence of intron 2 and overall dental implant failure, patients with the 2/2 genotype had a 3.07 OR of multiple implant failures when compared to patients with just one implant failure.[@CIT0018] This could indicate a role for IL-1RN in cluster implant failures. IL-1RN is involved in production of the IL-1ra cytokine, which has anti-inflammatory function.[@CIT0031] Both of these studies used patients from the same patient pool, so it could prove beneficial to test these polymorphisms on different patient pools to further examine the strength of association. Campos et al examined the IL-2 (−330) and IL-6 (−174) polymorphisms in a Brazilian population and found no significant association of either polymorphism with implant failure.[@CIT0012] IL-2 is secreted by activated T cells and induces proliferation in a variety of different lymphocytes.[@CIT0031] IL-6 has been shown to have pleiotropic functions which include stimulation of osteoclast formation, as well as induction of acute inflammatory factors.[@CIT0031]

The other major family of genes studied were the matrix metalloproteinases. Three of the articles examined MMP polymorphisms, with two of these articles finding statistically significant results. After tissue injury, matrix metalloproteinases have been found to have a variety of functions in the wound healing process.[@CIT0032] MMP-1 cleaves type 1 collagen at wound sites in order to promote integrin binding to keratinocytes.[@CIT0032] MMP-8 plays a major role in neutrophil recruitment.[@CIT0032] Costa Jr et al examined the MMP-8 (−799) polymorphism on a Brazilian population and found that 76.25% patients with early implant failure carried the T allele compared to only 60% of the control group.[@CIT0015] Leite et al examined the MMP-1 (−519) and (−1607) polymorphisms and found that 38.63% of patients with early implant failures carried the GG allele at the (−1607) position compared to 25% in the control group.[@CIT0014] They also found that 28.9% of the patients with early implant failure carried the (−519)/(−1607) G/GG haplotype compared to only 12.5% in the control group. Finally, Munhoz et al examined the MMP-3 (−1612) polymorphism in a Brazilian population and found no significant association with early implant failure.[@CIT0025] However, the authors note that the MMP-3 and MMP-1 are located in close proximity on chromosome 11, and further studies which examine the polymorphism in haplotype combination could prove beneficial. All three of these studies examined only non-smoking patients and included systemic diseases such as osteoporosis and HIV, which eliminates several major confounding factors. It must be noted that all three of these studies examined patients selected from the University of Campinas and only examined early implant failures. Additional studies which consider both early and late implant failures could help clarify the roles these polymorphisms play in affecting not only initial osseointegration, but also overall implant survival.

The three remaining articles examined miscellaneous polymorphisms not related to genes in other studies. Alvim-Pereira et al examined the Vitamin D receptor rs731236 in a Brazilian population and found no statistically significant associations.[@CIT0020] Doetzer et al examined three different Lactotransferrin polymorphisms (rs6441989, rs2073495, rs11716497) and found no clinically significant associations.[@CIT0021] However, this study did not have exclusion criteria of systemic diseases for its patient sample, which could present as confounding factors for the results. Finally, dos Santos et al examined two TGF-1β polymorphisms \[(−509), −800)\] and found no statistically significant associations while looking at early implant failures only.[@CIT0016]

Other factors associated with implant failure {#S0003-S2003}
---------------------------------------------

Several studies included in this review also examined other factors associated with dental implant failure. With regards to dental risk factors, four studies found a significant association between edentulism and implant failure.[@CIT0017],[@CIT0020],[@CIT0021],[@CIT0023] Associations were also found between number of implants placed and implant failure, as well as increased pocket probing depth and implant failure.[@CIT0017],[@CIT0018],[@CIT0020] Certain systemic factors were found to be associated with implant failure as well. In the study conducted by Jacobi-Gresser et al, although they failed to find a statistically significant association with individual IL-1B or TNF-α polymorphisms, they did find a significant association between increased TNF-α/IL-1B serum assay levels and dental implant failure (OR=12.01).[@CIT0024] Two studies which included medically compromised patients found a significant association between medical treatment for systemic disease and implant failure.[@CIT0017],[@CIT0021] One of these studies also found a significant association with hormonal replacement therapy (OR=2.085).[@CIT0021] Finally, one study found that males were more susceptible to implant failure than females (OR=2.78).[@CIT0024]

Discussion {#S0004}
==========

Our review identified 16 studies in total which analyzed the association between SNPs and dental implant failure. Overall, 22 different polymorphisms were analyzed, and statistically significant associations with implant failures were found for six of them, specifically the IL-4, IL-1A, IL-1B, MMP-8, and MMP-1 polymorphisms. The study which found significant results for the IL-1A and IL-1B polymorphisms suffered from a low sample size, so it is unclear if those results could be reproduced. In addition, two earlier studies examined the same IL-1A (−889) polymorphism and found no significant results. Based on these findings, the IL-4 (+33), MMP-8 (−799), MMP-1 (−519), and MMP-1 (−1617) show the highest association with dental implant failure. With the exception of the IL-4 (+33) polymorphism, all of these polymorphisms were the subject of studies which examined early failures only. This is most likely due to the role these genes play in the inflammatory and wound-healing process, which is one of the main factors affecting early implant failure.[@CIT0020],[@CIT0032]

There are some limitations to the studies that we have included in this review. First, not every study included differentiated between late and early implant failure. The mechanism of failure in early implant failure versus late implant failure differs, as early implant failure represents a failure in the osseointegration process, whereas in late implant failure osseointegration has already occurred.[@CIT0004],[@CIT0005] Thus, it may be necessary to treat these two types of implant failure as two distinct events when attempting to characterize risk factors. Second, the survival period to be considered an implant "success" varied widely between the selected studies. For some studies which examined all implant failures, the survival period was as short as 6 months. Future studies could benefit from expanding the required survival period to be considered an implant "success" in order to capture a greater range of late implant failure cases. The survival period also varied even between studies which only examined early implant failure.

According to the inclusion criteria for our scoping review, only original research articles with case-control design were included. Case-control studies were chosen as one of the criteria to ensure sufficient homogeneity of the resulting sample and because case-control design has been the most widely used approach in genetic association studies particularly concerning rare events such as implant failure.[@CIT0049] Case-control studies have been successfully used in identifying risk factors for periodontal disease,[@CIT0050] peri-implantitis,[@CIT0051] implant failure,[@CIT0052] and association of health care utilization with genetic polymorphisms.[@CIT0053] In case-control studies, subjects are grouped based on the outcome such as implant failure or success allowing comparison of exposure prevalence such as particular SNP between the groups. Unlike case-control studies, cohort studies group subjects based on the absence or presence of a particular exposure such as SNP to compare outcome frequencies in the study groups.[@CIT0054] Though case-control design is usually preferred for studies of rare conditions, cohort studies may also be used for this purpose. Though cohort studies were not included in this review based on the scoping review inclusion criteria, there is a number of valuable reports related to the genetic factors of dental implant failure. For example, Vaz et al demonstrated that particular alleles of IL1A and IL1B genes were significantly associated with dental implant failure.[@CIT0055] Another limitation of our study was that it was focused only on single dental implant survival. Articles focused on implants retaining overdentures such as the study by Fernandez et al.[@CIT0056] were not included to ensure sample homogeneity and due to a different role that the implant overload factors may play in these cases.

Other studies have also performed reviews on the available literature to find genetic associations with implant failure. In 2011, Dereka et al published a review that examined seven different studies.[@CIT0033] Their review found that no association has been demonstrated between TNF-α, IL-1, IL-2, IL-6, or TGF-β1 polymorphisms and dental implant complications. Our review differs from theirs in several ways. First, their review examined all biologic complications defined as "the biological processes that affect the soft and hard tissues supporting the implant." This broad definition resulted in inclusion of genetic polymorphisms studies which examined peri-implantitis or peri-implant bone loss in addition to implant failure. Our review only examined those studies which looked at the association between SNPs and actual implant loss because peri-implantitis has been found to occur in anywhere from 28% to 56% of dental implants placed, so it represents an outcome which is both more common and less disastrous than implant failure.[@CIT0033] Second, their exclusion and inclusion criteria differed from ours. They only included studies were the implant did not develop any complications for a minimum of 1 year after loading, whereas our review included multiple studies with a shorter minimum implant survival period. In addition, they excluded studies which examined medically compromised patients, whereas we included a few studies which included these patients in their study sample. Finally, they only included studies which examined both early and late implant loss, whereas we examined several studies which only included early implant failure. We included these studies in order to find a broader range of candidate genes which could play a role in implant failure. A 2018 review also examined the association between certain SNPs and dental implant failure in the literature.[@CIT0035] Like the above review, this study also excluded articles which included patients with systemic disease from their review. We felt that these studies were important to include because implant failure and other conditions of the periodontium have a multifactorial etiology with possible ties to systemic disease.[@CIT0036] The effect of gene polymorphisms could have interactions with these systemic conditions in implant failure, so we wanted to investigate papers which included these populations. Another review published in 2018 by del Valle et al also included a broad spectrum of articles investigating association between genetic polymorphisms and risk for biological complications in implantology,[@CIT0048] similar to the report by Dereka et al.[@CIT0033] A review by Alvim-Pereira et al provided a broad examination of the literature available regarding gene polymorphisms and implant failure but did not specify inclusion and exclusion criteria or search terms.[@CIT0037] The resulting conclusion of these reviews that new investigations are necessary to overcome limitations of previous studies was in concordance with the conclusion of our scoping review. Our article represents the first review in this field which followed the methodology of scoping review[@CIT0010] Following the scoping review requirements, strict inclusion and exclusion criteria were chosen to ensure quality control of the studies included in our review.

Dental implant placement is a complex surgical procedure and thus the etiology of its failure is often multifactorial. Although our review chooses to focus on possible genetic contributions, many of the articles included in this review identified other factors which could contribute to implant failure susceptibility, such as edentulism and smoking habits. Other factors which have been investigated for their relationship to dental implant outcomes include the implant position (anterior compared to posterior) and material.[@CIT0034] Continued investigation into all factors which could affect dental implant outcomes is needed in order to further improve the reliability and predictability of this treatment. Our findings indicate that very few studies have been made which examine the association between SNPs and dental implant loss. Of the few polymorphisms which have been examined, even fewer have been the subject of more than one study. In addition, of the few studies available there is a great deal of homogeneity with regards to the study samples used. Many of the studies included also have very short minimum implant survival periods ( \<1 year), which could be affecting the late implant failure rate. Further studies should be done on these polymorphisms with different sample populations in order to see if the results can be reproduced.

Conclusion {#S0005}
==========

Very few comprehensive studies have been done to identify SNP associated with dental implant failure. Existing studies are limited by a small sample size, choice of confounders, and population background. Additional studies with larger sample sizes and different ethnic backgrounds need to be done to see if the results can be reproduced. Of the polymorphisms studied, the IL-4 (+33), MMP-8 (−799), MMP-1 (−519), and MMP-1 (−1607) polymorphisms show the greatest association with dental implant loss.
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